The Latest Breaking News from Antibiotics

Without new antibiotics, the world is on track to re-enter the medical dark ages by 2050, when a simple cut could kill 10 million people a year. So why are they so hard to find?

Even before the COVID crisis, excessive use and misuse of lifesaving antibiotics had contributed to the emergence of resistant strains of disease-causing organisms. This has rendered many of the most powerful treatments in modern medicine ineffective.

Experts believe that antibiotic resistance will become a global problem in the long term, with a new study finding high rates of resistance in samples of salmon and beef.

In India in 2021, an estimated 504,000 people died from tuberculosis, or TB. That’s almost one per minute. More than a quarter of the estimated TB cases worldwide are in India.

Qualigen Therapeutics Inc (NASDAQ:QLGN) has agreed to acquire a majority stake in NanoSynex Ltd, an Israeli-based developer of next-generation diagnostics technology. NanoSynex's Antimicrobial Susceptibility Testing (AST) platform provides rapid, accurate, and personalized tests for bacterial infections to quickly match the correct antibiotics to treat a patient's particular infection.  Antibiotic misuse and overuse have given…

Coroner Peter Sigee said there was a catalogue of “individual and systemic failures” in Kingsley Olasupo’s care at Royal Bolton Hospital

Kingsley Olasupo's family are now campaigning for a permanent memorial to the tot to remind healthcare staff 'simple mistakes can lead to a catastrophic outcome'

"We let him down, and we let you down, and I'll always be sorry for that", Dr Kate Kewley said at an inquest, held at Bolton Coroner's Court

GlaxoSmithKline Plc's (NYSE:GSK) Q1 turnover reached £9.78 billion, up 32% Y/Y on actual exchange rate AER and constant exchange rate CER basis. Specialty Medicines turnover was £3.13 billion, up 98% AER, 97% CER (+16% AER, 15% CER excluding Xevudy), driven by consistent growth in all therapy areas, including sales of Xevudy.  Sales…